Drugs / MB07803
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00458016 | Mar 2007 → Mar 2008 | type 2 diabetes mellitus | Ligand Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MB07803 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00458016 ↗ |
| Modality | Small molecule | — CHEMBL4297400 ↗ |
| Route | Oral | “Daily oral administration” NCT00458016 ↗ |